Public Acceptance Of Biotechnology Depends On How Well Scientists Communicate The Facts

No matter how esoteric their pursuits may be, scientists cannot afford to be indifferent to public opinion. The nonscientific public, after all, strongly influences the direction of research and the disbursement of funding. And as scientific research is translated into product development, public acceptance can become the key determinant of success. It follows that researchers are wise to keep the public well informed on scientific undertakings--especially those projects that could potentially

Written byThomas Hoban
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

No matter how esoteric their pursuits may be, scientists cannot afford to be indifferent to public opinion. The nonscientific public, after all, strongly influences the direction of research and the disbursement of funding. And as scientific research is translated into product development, public acceptance can become the key determinant of success.

It follows that researchers are wise to keep the public well informed on scientific undertakings--especially those projects that could potentially be stymied or even aborted as a result of public ignorance, emotional prejudice, or fear. Serving as a case in point are the public's current attitudes toward food developed through biotechnology.

Earlier this year, I and several colleagues from around the United States--with advice from an interdisciplinary team of scientists--conducted phone interviews on this subject with a representative sampling of 1,228 U.S. adults. We found that awareness and understanding of biotechnology were rather low. However, respondents expressed considerable interest ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies